Quinidine gluconate (extended-release tablet): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 519: Line 519:
|brandNames=
|brandNames=


* ®<ref>{{Cite web | title = | url = }}</ref>
* Quinidine Gluconate®<ref>{{Cite web | title = QUINIDINE GLUCONATE tablet, extended release | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=738b8ff3-97d8-45be-a9f2-9a1c1b27f394 }}</ref>


<!--Look-Alike Drug Names-->
<!--Look-Alike Drug Names-->
Line 525: Line 525:
|lookAlike=
|lookAlike=


* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
* N/A<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>


<!--Drug Shortage Status-->
<!--Drug Shortage Status-->

Revision as of 18:52, 13 July 2014

Quinidine gluconate (extended-release tablet)
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gerald Chi

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content

Overview

Quinidine gluconate (extended-release tablet) is an antiarrhythmic that is FDA approved for the {{{indicationType}}} of . There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition1
  • Dosing Information
  • Dosage
Condition2
  • Dosing Information
  • Dosage
Condition3
  • Dosing Information
  • Dosage
Condition4
  • Dosing Information
  • Dosage

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Quinidine gluconate (extended-release tablet) in adult patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Quinidine gluconate (extended-release tablet) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding FDA-Labeled Use of Quinidine gluconate (extended-release tablet) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Quinidine gluconate (extended-release tablet) in pediatric patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Quinidine gluconate (extended-release tablet) in pediatric patients.

Contraindications

  • Condition1

Warnings

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content
  • Description

Precautions

  • Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Quinidine gluconate (extended-release tablet) in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Quinidine gluconate (extended-release tablet) in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Quinidine gluconate (extended-release tablet) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Quinidine gluconate (extended-release tablet) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Quinidine gluconate (extended-release tablet) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Quinidine gluconate (extended-release tablet) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral
  • Intravenous

Monitoring

There is limited information regarding Monitoring of Quinidine gluconate (extended-release tablet) in the drug label.

Condition1
  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Quinidine gluconate (extended-release tablet) in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Quinidine gluconate (extended-release tablet) in the drug label.

Pharmacology

Template:Px
Template:Px
Quinidine gluconate (extended-release tablet)
Systematic (IUPAC) name
(S)-(6-Methoxyquinolin-4-yl)((2R,4S,8R)-8-vinylquinuclidin-2-yl)methanol
Identifiers
CAS number 56-54-2
ATC code C01BA01
PubChem 441074
DrugBank DB00908
Chemical data
Formula Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox 
Mol. mass 324.417 g/mol
SMILES eMolecules & PubChem
Synonyms (2-ethenyl- 4-azabicyclo [2.2.2] oct- 5-yl)- (6-methoxyquinolin- 4-yl)- methanol,
Pharmacokinetic data
Bioavailability 70-80%
Metabolism 50-90% Hepatic
Half life 6-8h
Excretion Renal via urine
Therapeutic considerations
Pregnancy cat.

C(AU) C(US)

Legal status

Prescription Only (S4)(AU) ?(CA) POM(UK) [[Prescription drug|Template:Unicode-only]](US)

Routes Oral, IM

Mechanism of Action

Structure

File:Quinidine gluconate (extended-release tablet)01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Quinidine gluconate (extended-release tablet) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Quinidine gluconate (extended-release tablet) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Quinidine gluconate (extended-release tablet) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Quinidine gluconate (extended-release tablet) in the drug label.

Condition1
  • Description

How Supplied

Storage

There is limited information regarding Quinidine gluconate (extended-release tablet) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Quinidine gluconate (extended-release tablet) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Quinidine gluconate (extended-release tablet) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Quinidine gluconate (extended-release tablet) in the drug label.

Precautions with Alcohol

  • Alcohol-Quinidine gluconate (extended-release tablet) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • Quinidine Gluconate®[1]

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "QUINIDINE GLUCONATE tablet, extended release".
  2. ↑ "http://www.ismp.org". External link in |title= (help)


{{#subobject: 

 |Page Name=Quinidine gluconate (extended-release tablet)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage=
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}


{{#subobject: 

 |Label Page=Quinidine gluconate (extended-release tablet)
 |Label Name=Quinidine gluconate (extended-release tablet)11.png

}}


{{#subobject: 

 |Label Page=Quinidine gluconate (extended-release tablet)
 |Label Name=Quinidine gluconate (extended-release tablet)11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Quinidine_gluconate_(extended-release_tablet)&oldid=992888"